The Antidiabetic SGLT-2 Inhibitor Market is growing as healthcare providers increasingly focus on effective management of type 2 diabetes and related metabolic complications. Sodium-glucose cotransporter-2 inhibitors work by promoting urinary glucose excretion and have become an important class of medicines used in diabetes management. Their clinical relevance has expanded as research has...